Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Chilvers

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pediatric Pulmonology|July 31, 2019
An investigation into biomarkers for the diagnosis of ABPA and aspergillus disease in cystic fibrosisKaren Keown, Salome Abbott, Boris Kuzeljevic, et al.
JAMA Otolaryngology-- Head & Neck Surgery|August 22, 2014
Use of the SNOT-22 and UPSIT to appropriately select pediatric patients with cystic fibrosis who should be referred to an otolaryngologist: cross-sectional studyAndrew Thamboo, Rachelle C Dar Santos, Lalenthra Naidoo, et al.
Pediatric Nephrology (Berlin, Germany)|December 31, 2010
Renal function in pediatric cystic fibrosis patients in the first decade of lifeChanel Prestidge, Mark A Chilvers, A George F Davidson, et al.
Plos One|June 1, 2012
Inflammasome-mediated IL-1β production in humans with cystic fibrosisAnthony Tang, Ashish Sharma, Roger Jen, et al.
The Lancet. Respiratory Medicine|January 31, 2021
Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension studyMark A Chilvers, Jane C Davies, Carlos Milla, et al.
Immunology|January 28, 2010
Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosisSarah E Rzemieniak, Aaron F Hirschfeld, Rachel E Victor, et al.
Journal of Visualized Experiments : Jove|November 23, 2020
Nasal Brushing Sampling and Processing using Digital High Speed Ciliary Videomicroscopy - Adaptation for the COVID-19 PandemicNoemie Bricmont, Lionel Benchimol, Anne-Lise Poirrier, et al.
Annals of the American Thoracic Society|September 18, 2020
Epidemiology of <i>Burkholderia</i> Infections in People with Cystic Fibrosis in Canada between 2000 and 2017James E A Zlosnik, Deborah A Henry, Trevor J Hird, et al.
Annals of the American Thoracic Society|December 5, 2014
Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experienceJames E A Zlosnik, Guohai Zhou, Rollin Brant, et al.
Journal of Medical Microbiology|June 30, 2020
Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of <i>Burkholderia cepacia</i> complex and <i>Burkholderia gladioli</i> in the clinical microbiology laboratoryKendrew S K Wong, Suk Dhaliwal, Jennifer Bilawka, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pediatric Pulmonology|July 31, 2019
An investigation into biomarkers for the diagnosis of ABPA and aspergillus disease in cystic fibrosisKaren Keown, Salome Abbott, Boris Kuzeljevic, et al.
JAMA Otolaryngology-- Head & Neck Surgery|August 22, 2014
Use of the SNOT-22 and UPSIT to appropriately select pediatric patients with cystic fibrosis who should be referred to an otolaryngologist: cross-sectional studyAndrew Thamboo, Rachelle C Dar Santos, Lalenthra Naidoo, et al.
Pediatric Nephrology (Berlin, Germany)|December 31, 2010
Renal function in pediatric cystic fibrosis patients in the first decade of lifeChanel Prestidge, Mark A Chilvers, A George F Davidson, et al.
Plos One|June 1, 2012
Inflammasome-mediated IL-1β production in humans with cystic fibrosisAnthony Tang, Ashish Sharma, Roger Jen, et al.
The Lancet. Respiratory Medicine|January 31, 2021
Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension studyMark A Chilvers, Jane C Davies, Carlos Milla, et al.
Immunology|January 28, 2010
Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosisSarah E Rzemieniak, Aaron F Hirschfeld, Rachel E Victor, et al.
Journal of Visualized Experiments : Jove|November 23, 2020
Nasal Brushing Sampling and Processing using Digital High Speed Ciliary Videomicroscopy - Adaptation for the COVID-19 PandemicNoemie Bricmont, Lionel Benchimol, Anne-Lise Poirrier, et al.
Annals of the American Thoracic Society|September 18, 2020
Epidemiology of <i>Burkholderia</i> Infections in People with Cystic Fibrosis in Canada between 2000 and 2017James E A Zlosnik, Deborah A Henry, Trevor J Hird, et al.
Annals of the American Thoracic Society|December 5, 2014
Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experienceJames E A Zlosnik, Guohai Zhou, Rollin Brant, et al.
Journal of Medical Microbiology|June 30, 2020
Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of <i>Burkholderia cepacia</i> complex and <i>Burkholderia gladioli</i> in the clinical microbiology laboratoryKendrew S K Wong, Suk Dhaliwal, Jennifer Bilawka, et al.
Pageof 3